Pardes Biosciences Inc (PRDS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -21,440 | -38,518 | -24,171 | -12,659 | -4,523 |
| Accounts payable and accrued liabilities | 216 | 756 | 1,119 | 929 | -303 |
| Other Working Capital | -449 | 379 | 3,384 | 2,816 | 699 |
| Other Operating Activity | 1,311 | 465 | -469 | -623 | 379 |
| Operating Cash Flow | $-20,362 | $-36,918 | $-20,137 | $-9,537 | $-3,748 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 85,000 | N/A | 44,500 | N/A |
| Debt Repayment | N/A | -10,000 | N/A | N/A | N/A |
| Common Stock Issued | N/A | 198,937 | 4 | 4 | N/A |
| Other Financing Activity | -397 | 28,249 | 43,106 | -545 | 44,241 |
| Financing Cash Flow | $-397 | $302,186 | $43,110 | $43,959 | $44,241 |
| Beginning Cash Position | 268,678 | 3,410 | 3,410 | 3,410 | 3,410 |
| End Cash Position | 247,919 | 268,678 | 26,383 | 37,832 | 43,903 |
| Net Cash Flow | $-20,759 | $265,268 | $22,973 | $34,422 | $40,493 |
| Free Cash Flow | |||||
| Operating Cash Flow | -20,362 | -36,918 | -20,137 | -9,537 | -3,748 |
| Free Cash Flow | -20,362 | -36,918 | -20,137 | -9,537 | -3,748 |